Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: J Neurooncol. 2019 Jan 17;142(2):319–325. doi: 10.1007/s11060-019-03099-x

Figure 2.

Figure 2.

Representative images from a cervical spinal dural metastasis with high immunohistochemical expression for MAP3K7 (A) and CHD1 ( B), in comparison to low dual expression for these markers in 2 different patients with dural metastasis (C-F), the latter supratentorial (left frontal). Immunostaining for MAP3K7 (C, E) and CHD1 (D, F), with light hematoxylin counterstain, all 200X.